title: Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?
authors.affiliation: Division of Endocrinology, Police Medical Centre of Thessaloniki , Sarantaporou 10, Thessaloniki, 54 640 , Greece.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Anagnostis
authors.forename: Spyridon N
authors.initials: SN
authors.lastname: Karras
authors.forename: Dimitrios G
authors.initials: DG
authors.lastname: Goulis
mesh_terms: D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001842:Bone and Bones / Q000187:drug effects* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D016103:Spinal Fractures / Q000517:prevention & control*; D019379:Teriparatide / Q000008:administration & dosage*
chemical_list: D050071:Bone Density Conservation Agents; D019379:Teriparatide